The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney ...

If you purchased or acquired securities in Merck between February 3, 2022 and February 3, 2025 and would like to discuss your ...

Vaccines dominate the poultry pharmaceuticals market due to rising concerns over infectious diseases like Newcastle Disease and Avian Influenza. Regulatory restrictions on antibiotics further boost ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

Palantir is gaining significant traction in the tech world with its AI-driven services, experiencing a dramatic stock ...

Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...